Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$6.25
Total Value
$260.62K
Shares Held After
1,836,153
% of Holdings
2.2%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
15,771
Price
$156.53
Total Value
$2.47M
Shares Held After
51,871
% of Holdings
23.3%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
4,151
Price
$155.06
Total Value
$643.65K
Shares Held After
67,642
% of Holdings
5.8%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
4,852
Price
$153.93
Total Value
$746.87K
Shares Held After
71,793
% of Holdings
6.3%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
3,147
Price
$1.96
Total Value
$6.17K
Shares Held After
79,353
% of Holdings
3.8%
Caribou Biosciences, Inc. (CRBU)
Khan Ruhi Ahmad — Chief Business Officer
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
104,998
% of Holdings
6.2%
Caribou Biosciences, Inc. (CRBU)
MCCLUNG BARBARA G — Chief Legal Officer
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
481,564
% of Holdings
1.4%
Caribou Biosciences, Inc. (CRBU)
Albertson Tina M. — Chief Medical Officer
Shares
1,066
Price
$1.96
Total Value
$2.09K
Shares Held After
68,523
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
736
Price
$18.15
Total Value
$13.36K
Shares Held After
325,059
% of Holdings
0.2%
Ovid Therapeutics Inc. (OVID)
ALEXANDER MARGARET A. — Director
Shares
11,656
Price
$1.45
Total Value
$16.90K
Shares Held After
61,750
% of Holdings
15.9%
Ovid Therapeutics Inc. (OVID)
Rona Jeffrey A — CBFO
Shares
8,541
Price
$1.45
Total Value
$12.38K
Shares Held After
88,188
% of Holdings
8.8%
Candel Therapeutics, Inc. (CADL)
Manning Paul B — Director
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%
Vera Therapeutics, Inc. (VERA)
Skelton Laurence Matthew — Chief Commercial Officer
Shares
1,582
Price
$41.98
Total Value
$66.42K
Shares Held After
64,218
% of Holdings
2.4%
Vera Therapeutics, Inc. (VERA)
Brenner Robert — Chief Medical Officer
Shares
2,151
Price
$41.98
Total Value
$90.31K
Shares Held After
50,947
% of Holdings
4.1%
Vera Therapeutics, Inc. (VERA)
Grant Sean — CHIEF FINANCIAL OFFICER
Shares
4,949
Price
$41.98
Total Value
$207.78K
Shares Held After
114,181
% of Holdings
4.2%
Vera Therapeutics, Inc. (VERA)
Turner William D. — Chief Regulatory Officer
Shares
2,187
Price
$41.98
Total Value
$91.82K
Shares Held After
45,313
% of Holdings
4.6%
Vera Therapeutics, Inc. (VERA)
JOHNSON DAVID LEE — Chief Operating Officer
Shares
2,579
Price
$41.98
Total Value
$108.28K
Shares Held After
45,727
% of Holdings
5.3%
Vera Therapeutics, Inc. (VERA)
Young Joseph R — SVP, FINANCE, CHIEF ACCT OFFCR
Shares
3,117
Price
$41.98
Total Value
$130.86K
Shares Held After
64,722
% of Holdings
4.6%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
16,925
Price
$41.98
Total Value
$710.58K
Shares Held After
257,163
% of Holdings
6.2%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
20,056
Price
$8.28
Total Value
$166.06K
Shares Held After
3,013,022
% of Holdings
0.7%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
3,057
Price
$8.28
Total Value
$25.31K
Shares Held After
323,368
% of Holdings
0.9%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
2,810
Price
$8.28
Total Value
$23.27K
Shares Held After
269,108
% of Holdings
1.0%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,759
Price
$8.28
Total Value
$14.56K
Shares Held After
330,653
% of Holdings
0.5%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
200
Price
$48.48
Total Value
$9.70K
Shares Held After
98,445
% of Holdings
0.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
857
Price
$47.86
Total Value
$41.01K
Shares Held After
98,645
% of Holdings
0.9%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
7,427
Price
$46.94
Total Value
$348.64K
Shares Held After
99,502
% of Holdings
6.9%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
3,748
Price
$12.16
Total Value
$45.58K
Shares Held After
149,696
% of Holdings
2.4%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
153,444
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
2,571
Price
$12.16
Total Value
$31.26K
Shares Held After
147,623
% of Holdings
1.7%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
150,194
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Loomis David K — Chief Accounting Officer
Shares
1,108
Price
$12.16
Total Value
$13.47K
Shares Held After
29,692
% of Holdings
3.6%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
160,009
Price
$48.84
Total Value
$7.81M
Shares Held After
1,457,427
% of Holdings
9.9%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$45.32
Total Value
$84.97K
Shares Held After
47,636
% of Holdings
3.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$45.32
Total Value
$1.49M
Shares Held After
131,664
% of Holdings
20.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
3,419
Price
$14.14
Total Value
$48.35K
Shares Held After
141,274
% of Holdings
2.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.47
Total Value
$147.00K
Shares Held After
1,904,186
% of Holdings
5.3%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
0
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
3,975
Price
$15.57
Total Value
$61.88K
Shares Held After
47,003
% of Holdings
7.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
10,034
Price
$15.57
Total Value
$156.20K
Shares Held After
442,883
% of Holdings
2.2%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
165,000
Price
$10.25
Total Value
$1.69M
Shares Held After
2,925,821
% of Holdings
5.3%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
5,354
Price
$15.57
Total Value
$83.34K
Shares Held After
138,983
% of Holdings
3.7%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
4,347
Price
$15.57
Total Value
$67.67K
Shares Held After
226,701
% of Holdings
1.9%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,829
Price
$7.45
Total Value
$13.63K
Shares Held After
71,043
% of Holdings
2.5%
Vir Biotechnology, Inc. (VIR)
De Backer Marianne — Director
Shares
19,039
Price
$7.45
Total Value
$141.89K
Shares Held After
1,035,466
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,767
Price
$15.57
Total Value
$27.51K
Shares Held After
13,762
% of Holdings
11.4%
Vir Biotechnology, Inc. (VIR)
de Verneuil Vanina — EVP, General Counsel, Corp Sec
Shares
4,445
Price
$7.45
Total Value
$33.13K
Shares Held After
129,799
% of Holdings
3.3%
Vir Biotechnology, Inc. (VIR)
O'Byrne Jason — EVP & Chief Financial Officer
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
164,249
% of Holdings
1.3%
Vir Biotechnology, Inc. (VIR)
Eisner Mark — EVP and Chief Medical Officer
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
157,529
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
476
Price
$19.06
Total Value
$9.07K
Shares Held After
325,795
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
10,788
Price
$18.39
Total Value
$198.39K
Shares Held After
326,271
% of Holdings
3.2%
Showing 151–200 of 936 transactions (page 4 of 19)